TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11916898

Group type: EXPERIMENTAL
Intervention: Snowboarding
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: Alpine skiing
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: Age <16 years
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: More than five days of experience in the current season
Number of subjects: 674

Group type: EXPERIMENTAL
Intervention: At least one week of experience in total
Number of subjects: 674

Group type: COMPARATOR
Intervention: Control group (uninjured individuals)
Number of subjects: 674
Study: 9766290

Group type: EXPERIMENTAL
Intervention: Therapeutic Touch (TT) and dialogue (10 minutes of TT and 20 minutes of dialogue)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Quiet time and dialogue (10 minutes of quiet time and 20 minutes of dialogue)
Number of subjects: 29
Study: 7877288

Group type: EXPERIMENTAL
Intervention: Training with highly agreed intervals
Number of subjects: 30

Group type: COMPARATOR
Intervention: Training with poorly agreed intervals
Number of subjects: 30

Group type: COMPARATOR
Intervention: Training with randomly selected intervals
Number of subjects: 30

Group type: COMPARATOR
Intervention: Equivalent exposure to intervals without feedback
Number of subjects: 30
Study: 3041354

Group type: EXPERIMENTAL
Intervention: Sandoglobulin (immunoglobulin prepared for intravenous administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunotherapy with Sandoglobulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parenteral albumin
Number of subjects: 0
Study: 28914720

Group type: EXPERIMENTAL
Intervention: Thoracic corrective exercise program (1 hour/session, twice per week for 8 weeks, total of 16 sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Education on thoracic corrective exercise program and a booklet of exercises (Control Group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Thoracic corrective exercise program
Number of subjects: 50
Study: 30541093

Group type: EXPERIMENTAL
Intervention: Whole-grain wheat (WGW) 98 g/d
Number of subjects: 50

Group type: COMPARATOR
Intervention: Refined wheat (RW) 98 g/d
Number of subjects: 50
Study: 28394951

Group type: EXPERIMENTAL
Intervention: Healthful dietary pattern (consumption of fruits, vegetables, legumes, bread, rusk, and pasta)
Number of subjects: 1485

Group type: EXPERIMENTAL
Intervention: Adjusted for carbohydrate percentage
Number of subjects: 1485
Study: 24484688

Group type: EXPERIMENTAL
Intervention: Subcutaneous hydration (up to 1.5 l/day for 72 hours)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Intravenous hydration (up to 1.5 l/day for 72 hours)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Subcutaneous hydration
Number of subjects: 67
Study: 22233189

Group type: EXPERIMENTAL
Intervention: Very low-dose naltrexone (VLNTX) 0.125 or 0.25 mg/day
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Very low-dose naltrexone (VLNTX) + clonidine (0.1-0.2 mg q6h)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Clonidine (0.1-0.2 mg q6h)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Naltrexone placebo
Number of subjects: 127
Study: 21054829

Group type: EXPERIMENTAL
Intervention: Intervention group (counselling on daily physical activity, physical fitness training, sports advice)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment; current policy)
Number of subjects: 60
Study: 17391155

Group type: EXPERIMENTAL
Intervention: 0.5% aminophylline cream applied to the waist twice a day
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment (control) applied to the waist
Number of subjects: 50
Study: 15766477

Group type: EXPERIMENTAL
Intervention: Kaiku's Benecol containing 2 g/bottle of plant stanol esters
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (same product without plant stanol)
Number of subjects: 32
Study: 12018956

Group type: EXPERIMENTAL
Intervention: Phenobarbitone (prophylactic treatment)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (treated after first seizure)
Number of subjects: 37
Study: 9831406

Group type: EXPERIMENTAL
Intervention: Triple therapy (bismuth subnitrate 3 x 375 mg for 4 weeks + tetracycline 3 x 500 mg + metronidazole 3 x 250 mg daily for 2 weeks)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Dual therapy (amoxicillin 2 x 1000 mg + omeprazole 2 x 20 mg daily for 2 weeks)
Number of subjects: 101
Study: 7798414

Group type: EXPERIMENTAL
Intervention: Acral lentiginous melanoma (ALM)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Acral (nonlentiginous) melanoma
Number of subjects: 165
Study: 3190971

Group type: EXPERIMENTAL
Intervention: Neostigmine 2.5 mg and atropine 1.2 mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: No drugs to facilitate antagonism of blockade (Control)
Number of subjects: 38
Study: 5293942

Group type: EXPERIMENTAL
Intervention: Brinaldix
Number of subjects: 17
Study: 7435720

Group type: EXPERIMENTAL
Intervention: Outpatient clerkship
Number of subjects: 80

Group type: COMPARATOR
Intervention: Inpatient psychiatry
Number of subjects: 80
Study: 31311509

Group type: EXPERIMENTAL
Intervention: Free healthy school meal served every school day for one year
Number of subjects: 164
Study: 28389799

Group type: EXPERIMENTAL
Intervention: PaCO2 levels 36‐40 mmHg (Group 1)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: PaCO2 levels 41‐45 mmHg (Group 2)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: PaCO2 levels 46‐50 mmHg (Group 3)
Number of subjects: 400
Study: 25888838

Group type: EXPERIMENTAL
Intervention: Modified Mother-Infant Transaction Program (8 one-hour sessions + 4 home visits)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Modified Mother-Infant Transaction Program
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control group (standard care according to hospital guidelines)
Number of subjects: 221
Study: 23711332

Group type: EXPERIMENTAL
Intervention: Correct information about reflex areas (eye reflex area at the base of the second toe)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Pseudo-information about reflex areas (shoulder reflex area at the base of the third toe)
Number of subjects: 32
Study: 21272067

Group type: EXPERIMENTAL
Intervention: Phototherapy (PTx)
Number of subjects: 1972

Group type: COMPARATOR
Intervention: No Phototherapy (NoPTx)
Number of subjects: 1972
Study: 20509517

Group type: EXPERIMENTAL
Intervention: Additional intraoperative aerostasis with 100% autologous fibrin glue (AFG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 100
Study: 17541328

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 77

Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 77
Study: 15480592

Group type: EXPERIMENTAL
Intervention: Actual motor execution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mental motor imagery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preparation period of motor acts
Number of subjects: 0
Study: 11247549

Group type: EXPERIMENTAL
Intervention: DOTS with direct observation of treatment by health workers
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: DOTS with direct observation of treatment by family members
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Self-administered treatment
Number of subjects: 497
Study: 9661989

Group type: EXPERIMENTAL
Intervention: Stress session for all groups except for restrainers who smoked ad lib.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Smoke-abstinent restrainers during the stress session
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Restrainers
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control session
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Food intake
Number of subjects: 48
Study: 7876505

Group type: EXPERIMENTAL
Intervention: Oral mesalamine (Asacol) 3.2 g/day
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 3284724

Group type: EXPERIMENTAL
Intervention: Cefotaxime (2 gm, intravenously, three times on the day of surgery)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Penicillin and streptomycin (penicillin, 2 ml, IU, intramuscularly, three times daily for six days; streptomycin, 0.5 gm, intramuscularly, two times daily for four days)
Number of subjects: 100
Study: 31180763

Group type: EXPERIMENTAL
Intervention: Home-based exercise programme with monthly reinforcement sessions
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 160
Study: 28625567

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham TENS (Control)
Number of subjects: 28
Study: 25927495

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (CBT) program
Number of subjects: 160

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 160
Study: 23734126

Group type: EXPERIMENTAL
Intervention: Adaptive working memory training scheme
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-adaptive version of the program (Control)
Number of subjects: 36
Study: 22198602

Group type: EXPERIMENTAL
Intervention: AN69ST membrane
Number of subjects: 54

Group type: COMPARATOR
Intervention: Polysulfone F60 membrane
Number of subjects: 54
Study: 19812871

Group type: EXPERIMENTAL
Intervention: Tramiprosate 100 mg
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: Tramiprosate 150 mg
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1052
Study: 16508926

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate (MTX) plus infliximab
Number of subjects: 0
Study: 14529954

Group type: EXPERIMENTAL
Intervention: 325 mg lamotrigine (LTG) as a single dose
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: bi-hourly graded cumulative dose of lamotrigine (LTG)
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 10716041

Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tolbutamide 500 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 8
Study: 9420845

Group type: EXPERIMENTAL
Intervention: Ethanol (1 mL/kg 95% ethanol)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Carbohydrate punch (isocaloric)
Number of subjects: 7
Study: 2020905

Group type: EXPERIMENTAL
Intervention: Anticoagulant treatment (AC group)
Number of subjects: 188

Group type: COMPARATOR
Intervention: No anticoagulant treatment (O group)
Number of subjects: 188
Study: 7039927

Group type: EXPERIMENTAL
Intervention: Indomethacin (0.2 mg/kg for 2 doses, orally, 24 hours apart)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 47
Study: 29749112

Group type: EXPERIMENTAL
Intervention: Technology-enhanced writing therapy (12 hours)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (waitlist, no therapy for 6 weeks)
Number of subjects: 21
Study: 29465679

Group type: EXPERIMENTAL
Intervention: Data to Care intervention (medical provider contact, patient contact, structured individual interview)
Number of subjects: 822

Group type: COMPARATOR
Intervention: Control period (no intervention)
Number of subjects: 822
Study: 26892695

Group type: EXPERIMENTAL
Intervention: 200μg sublingual misoprostol
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 400μg sublingual misoprostol
Number of subjects: 124

Group type: COMPARATOR
Intervention: Comparison of 200μg vs 400μg
Number of subjects: 124
Study: 24156566

Group type: EXPERIMENTAL
Intervention: Glycopyrronium 50 μg o.d.
Number of subjects: 1888

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1888

Group type: COMPARATOR
Intervention: Tiotropium 18 μg o.d.
Number of subjects: 1888
Study: 22414198

Group type: EXPERIMENTAL
Intervention: Peer-led self-management coaching intervention (three home visits by an expert patient)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Peer-led self-management coaching intervention
Number of subjects: 133

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 133
Study: 20155327

Group type: EXPERIMENTAL
Intervention: Intensified treatment (n = 255)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Routine treatment according to Dutch guidelines (n = 243)
Number of subjects: 498
Study: 18089478

Group type: EXPERIMENTAL
Intervention: Active treatment (fix combination of 4/1.25 mg perindopril/indapamide)
Number of subjects: 861

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 861
Study: 16002812

Group type: EXPERIMENTAL
Intervention: Soy formula
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed whey formula
Number of subjects: 168

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 168
Study: 12421054

Group type: EXPERIMENTAL
Intervention: Endogenous and exogenous saccades programmed in a common saccade map.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Top‐down, location‐specific inhibition of locations to which the saccade should not go.
Number of subjects: 0
Study: 10338459

Group type: EXPERIMENTAL
Intervention: valsartan 160 mg BID
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: valsartan 80 mg BID
Number of subjects: 83

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 83
Study: 7489145

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF (250 micrograms/m2/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: rhG‐CSF (10 micrograms/kg/day)
Number of subjects: 34
Study: 1658183

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lisinopril 10 mg daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lisinopril and physical training
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Physical training alone
Number of subjects: 12
Study: 7148456

Group type: COMPARATOR
Intervention: Smokers
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Non-smokers
Number of subjects: 23
Study: 31813170

Group type: EXPERIMENTAL
Intervention: Blondes (VAS for fun sitting upright)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-blondes (VAS for fun sitting upright)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Blondes (VAS for fun lying down)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Non-blondes (VAS for fun lying down)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Waterslide lying down (VAS for fun)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waterslide sitting upright (VAS for fun)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Waterslide lying down (duration)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Waterslide sitting upright (duration)
Number of subjects: 21
Study: 28562099

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone gel 1% (androgel) before Controlled Ovarian Stimulation (COS)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no testosterone gel)
Number of subjects: 110
Study: 26801905

Group type: EXPERIMENTAL
Intervention: Dexketoprofen/tramadol 25 mg/75 mg
Number of subjects: 606

Group type: COMPARATOR
Intervention: Dexketoprofen 25 mg
Number of subjects: 606

Group type: COMPARATOR
Intervention: Tramadol 100 mg
Number of subjects: 606

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 606
Study: 25412338

Group type: EXPERIMENTAL
Intervention: Glutamine (15 g bd) + sitagliptin (100 mg/d)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Glutamine (15 g bd) + placebo
Number of subjects: 13
Study: 23005589

Group type: EXPERIMENTAL
Intervention: Antenatal emotional self-management training program
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study: 19833616

Group type: EXPERIMENTAL
Intervention: DCT1
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: OPA1
Number of subjects: 350

Group type: COMPARATOR
Intervention: DCT2
Number of subjects: 350
Study: 17722962

Group type: EXPERIMENTAL
Intervention: Tacrolimus once-daily (OD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard tacrolimus (twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ciclosporin microemulsion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tacrolimus OD
Number of subjects: 0
Study: 16221103

Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide (IVC) 0.75-1 g/m² monthly for 6 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Mycophenolate mofetil (MMF) 2 g/day for 6 months
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups (IVC and MMF)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide (IVC)
Number of subjects: 44
Study: 12364686

Group type: EXPERIMENTAL
Intervention: Mini Mental State Examination (MMSE)
Number of subjects: 37
Study: 10193958

Group type: EXPERIMENTAL
Intervention: Coherent UltraPulse
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Tissue Technologies TruPulse
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Sharplan FeatherTouch
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Luxar NovaPulse
Number of subjects: 7
Study: 1579769

Group type: EXPERIMENTAL
Intervention: Pacifier
Number of subjects: 42

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 42
Study: 2990196

Group type: EXPERIMENTAL
Intervention: 0.4 M NaHCO3
Number of subjects: 14

Group type: COMPARATOR
Intervention: 0.4 M NaCl
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 30 ml of liquid antacid (aluminum and magnesium hydroxide)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied)
Number of subjects: 14
Study: 30903117

Group type: EXPERIMENTAL
Intervention: Palatal implants
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Mini-screws
Number of subjects: 27

Group type: COMPARATOR
Intervention: Palatal implants or mini-screws
Number of subjects: 27
Study: 30020886

Group type: EXPERIMENTAL
Intervention: Mud pack to eyes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wet pack to eyes
Number of subjects: 60
Study: 27501056

Group type: EXPERIMENTAL
Intervention: Digital palpation of the pilot balloon
Number of subjects: 180

Group type: COMPARATOR
Intervention: Continuous manometry
Number of subjects: 180
Study: 26416195

Group type: EXPERIMENTAL
Intervention: Right-sided starting position (RL)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Left-sided starting position (LL)
Number of subjects: 163
Study: 24151591

Group type: EXPERIMENTAL
Intervention: Test product (cyclobenzaprine tablet)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Reference product (cyclobenzaprine tablet)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both test and reference products
Number of subjects: 23
Study: 21127191

Group type: EXPERIMENTAL
Intervention: Eyes closed comfortable stance condition
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Model including medial-lateral sway velocity, anterior-posterior short-term α-scaling exponent, medial-lateral short-term α-scaling exponent, mean frequency, body mass index, and age
Number of subjects: 150
Study: 18815572

Group type: COMPARATOR
Intervention: 600‐m jog
Number of subjects: 68

Group type: COMPARATOR
Intervention: 600‐m jog followed by a dynamic stretching routine
Number of subjects: 68

Group type: COMPARATOR
Intervention: 600‐m jog followed by a proprioceptive neuromuscular facilitation (PNF) routine
Number of subjects: 68
Study: 16552831

Group type: EXPERIMENTAL
Intervention: Manual acupuncture stimulation (MAS) at LI 4 point in the right thenar muscle for 2 minutes
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (2 minutes of rest instead of MAS)
Number of subjects: 12
Study: 14696632

Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 11033132

Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.2 mg/mL for 2 minutes) with releasable sutures (Group 1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Permanent sutures (Group 2)
Number of subjects: 36
Study: 9388397

Group type: EXPERIMENTAL
Intervention: Community-level intervention involving popular homosexual men advocating behaviour change to peers.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control cities received HIV educational materials in bars.
Number of subjects: 0
Study: 7713197

Group type: EXPERIMENTAL
Intervention: MDI containing salmeterol xinafoate (MDI-S)
Number of subjects: 11850

Group type: EXPERIMENTAL
Intervention: MDI containing lecithin NF (MDI-L)
Number of subjects: 11850

Group type: EXPERIMENTAL
Intervention: MDI containing oleic acid (MDI-OA)
Number of subjects: 11850

Group type: COMPARATOR
Intervention: MDI-S
Number of subjects: 11850
Study: 3453431

Group type: COMPARATOR
Intervention: Nicergoline (30 mg twice a day) for 6 months (double-blind for PICD patients)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Nicergoline (30 mg twice a day) for at least 6 months (open design for PAD patients)
Number of subjects: 11
Study: 29154884

Group type: EXPERIMENTAL
Intervention: EXP + GNG (cue exposure with Go/No Go training)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: EXP + shamGNG (cue exposure with sham training)
Number of subjects: 71

Group type: COMPARATOR
Intervention: CON + shamGNG (control procedure with sham training)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 71
Study: 27522220

Group type: EXPERIMENTAL
Intervention: Social Skills Training (SST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 0
Study: 24825805

Group type: EXPERIMENTAL
Intervention: Intramuscular meperidine injection administered 30 minutes before the biopsy
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Periprostatic nerve block (PNB) by injection 10 minutes prior to the prostate biopsy
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (n = 62)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 186
Study: 23554497

Group type: EXPERIMENTAL
Intervention: Greater effort exerted during anticipation of winning money
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Effort exerted
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anticipation of effort
Number of subjects: 0
Study: 19875270

Group type: EXPERIMENTAL
Intervention: Mental practice followed by physical practice
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Physical practice
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mental practice
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Physical practice followed by mental practice
Number of subjects: 40

Group type: COMPARATOR
Intervention: No practice
Number of subjects: 40